Serum Lipocalin-2 as an Insulin Resistance Marker in Patients with Polycystic Ovary Syndrome

    Erman Cakal, Mesut Ozkaya, Yaprak Engin Üstün, Yusuf Üstün
    Studysummary In this study, women with polycystic ovary syndrome had significantly higher lipocalin-2 levels compared to controls, suggesting it may be a useful marker for insulin resistance in this population.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →